{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:48:08Z","timestamp":1776872888000,"version":"3.51.2"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.semerg.2026.102696","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T22:07:39Z","timestamp":1771452459000},"page":"102696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluaci\u00f3n de la efectividad de una intervenci\u00f3n para la deprescripci\u00f3n de la aspirina en prevenci\u00f3n primaria de la enfermedad cardiovascular"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3594-3795","authenticated-orcid":false,"given":"A.","family":"Hern\u00e1ndez Girb\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3842-8796","authenticated-orcid":false,"given":"I.","family":"Moral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0630-1035","authenticated-orcid":false,"given":"P.","family":"Bruning Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3073-514X","authenticated-orcid":false,"given":"L.","family":"Cuixart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chaboun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8486-3265","authenticated-orcid":false,"given":"C.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-6581","authenticated-orcid":false,"given":"C.","family":"Brotons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2026.102696_bib0105","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2026.102696_bib0110","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2026.102696_bib0115","unstructured":"CIMA. Ficha t\u00e9cnica AAS 100mg, comprimidos [consultado 1 Abr 2025]. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/42991\/fichatecnica_42991.html"},{"key":"10.1016\/j.semerg.2026.102696_bib0120","first-page":"104","article-title":"Prescription prevalence of low dose aspirin in primary prevention in the Spanish population, trends over time and associated factors","volume":"155","author":"Rodr\u00edguez-Mart\u00edn","year":"2020","journal-title":"Med Clin (Engl Ed)."},{"key":"10.1016\/j.semerg.2026.102696_bib0125","doi-asserted-by":"crossref","first-page":"100256","DOI":"10.1016\/j.ajpc.2021.100256","article-title":"Aspirin for cardiovascular disease prevention among adults in the United States: trends, prevalence, and participant characteristics associated with use","volume":"8","author":"Boakye","year":"2021","journal-title":"Am J Prev Cardiol."},{"key":"10.1016\/j.semerg.2026.102696_bib0130","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurjpc\/zwad092","article-title":"Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetes","volume":"30","author":"Kristensen","year":"2023","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.semerg.2026.102696_bib0135","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.semerg.2026.102696_bib0140","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2026.102696_bib0145","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med."},{"issue":"Suppl. 1","key":"10.1016\/j.semerg.2026.102696_bib0150","first-page":"S207","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care."},{"key":"10.1016\/j.semerg.2026.102696_bib0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semerg.2021.12.002","article-title":"Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: a scoping review","volume":"48","author":"Ruiz-Garc\u00eda","year":"2022","journal-title":"Semergen."},{"key":"10.1016\/j.semerg.2026.102696_bib0160","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2019.03.501","article-title":"Aspirin for primary prevention of cardiovascular events","volume":"73","author":"Abdelaziz","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.semerg.2026.102696_bib0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.semerg.2026.102696_bib0170","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement","volume":"327","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.semerg.2026.102696_bib0175","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2026.102696_bib0180","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/eurheartj\/ehae302","article-title":"When cardiovascular medicines should be discontinued","volume":"45","author":"Krychtiuk","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2026.102696_bib0185","unstructured":"StataCorp. 2023. Stata 18 Multiple-Imputation Reference Manual. College Station, TX: Stata Press [consultado 11 Abr 2025].Disponible en: www.stata.com"},{"key":"10.1016\/j.semerg.2026.102696_bib0190","doi-asserted-by":"crossref","first-page":"e002457","DOI":"10.1136\/bmjoq-2023-002457","article-title":"Identifying and reducing inappropriate aspirin use in primary care","volume":"12","author":"Brooker","year":"2023","journal-title":"BMJ Open Qual."},{"key":"10.1016\/j.semerg.2026.102696_bib0195","doi-asserted-by":"crossref","first-page":"105899","DOI":"10.1016\/j.ijmedinf.2025.105899","article-title":"Understanding potentially inappropriate medication: a focus group study with general practitioners","volume":"199","author":"Rodrigues","year":"2025","journal-title":"Int J Med Inform."},{"key":"10.1016\/j.semerg.2026.102696_bib0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4140\/TCP.n.2024.212","article-title":"Pharmacist-led deprescribing of aspirin in older people in an outpatient setting","volume":"39","author":"Ramos","year":"2024","journal-title":"Sr Care Pharm."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:52:54Z","timestamp":1776869574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359326000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1138359326000134"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102696","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluaci\u00f3n de la efectividad de una intervenci\u00f3n para la deprescripci\u00f3n de la aspirina en prevenci\u00f3n primaria de la enfermedad cardiovascular","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102696"}}